With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.

Therapeutics

Biotechnology

Paragon Bioservices, Inc.

Pete Buzy

Orlando Lopez

Lynn Betts

Fred Plog

Erica Chacon

Carrie Thompson

Jacqueline Parks

The Manufacturing and Production team at Paragon Bioservices, Inc. specializes in the development, scale-up, and production of viral vectors and cell therapies. This team ensures the efficient and high-quality manufacturing of adeno-associated virus (AAV) and lentiviral vectors, as well as CAR-T immunotherapies. Their responsibilities include upstream and downstream processing, fill-finish operations, and rigorous quality control to support clinical and commercial programs in advanced biotherapeutics.

Manufacturing and Production

Quality Assurance Team

Scientists and Development

Manufacturing and Production

About

Team members

Other teams at Paragon Bioservices, Inc.

Quality Assurance Team

Scientists and Development